0001209191-13-014695.txt : 20130306 0001209191-13-014695.hdr.sgml : 20130306 20130306191438 ACCESSION NUMBER: 0001209191-13-014695 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130302 FILED AS OF DATE: 20130306 DATE AS OF CHANGE: 20130306 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Erck Stanley C CENTRAL INDEX KEY: 0001342826 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26770 FILM NUMBER: 13671147 MAIL ADDRESS: STREET 1: 20 FIRSTFIELD ROAD, #250 CITY: GAITHERSBURG STATE: MD ZIP: 20878 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NOVAVAX INC CENTRAL INDEX KEY: 0001000694 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 222816046 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9920 BELWARD CAMPUS DRIVE CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 240-268-2000 MAIL ADDRESS: STREET 1: 9920 BELWARD CAMPUS DRIVE CITY: ROCKVILLE STATE: MD ZIP: 20850 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2013-03-02 0 0001000694 NOVAVAX INC NVAX 0001342826 Erck Stanley C C/O 9920 BELWARD CAMPUS DRIVE ROCKVILLE MD 20850 1 1 0 0 President and CEO Options-right to buy 1.83 2013-03-02 4 A 0 900000 1.83 A 2023-03-02 Common Stock 900000 2970000 D Options shall vest in four equal annual installments beginning on the first anniversary of the date of grant. /s/ John Herrmann, Attorney-in-fact for Stanley Erck 2013-03-06